cs-1008
Showing 1 - 5 of 5
Colorectal Tumors Trial in Melbourne (CS-1008)
Completed
- Colorectal Neoplasms
- CS-1008
-
Melbourne, Victoria, AustraliaLudwig Institute Tumor Targeting Program, Austin Health
Oct 3, 2022
Ovarian Cancer Stage IIIC, Ovarian Cancer Stage IV Trial in Birmingham, Saint Louis, Oklahoma City (CS-1008, Paclitaxel,
Completed
- Ovarian Cancer Stage IIIC
- Ovarian Cancer Stage IV
- CS-1008
- +2 more
-
Birmingham, Alabama
- +2 more
Mar 11, 2021
NSCLC Trial in Gauting, Grobhansdorf (CS-1008, Placebo, Paclitaxel)
Completed
- Non-small Cell Lung Cancer
- CS-1008
- +3 more
-
Gauting, Germany
- +1 more
Sep 7, 2012
Metastatic Colorectal Cancer Trial in United Kingdom (CS-1008, irinotecan)
Terminated
- Metastatic Colorectal Cancer
- CS-1008
- irinotecan
-
Chelmsford, Essex, United Kingdom
- +8 more
Jan 30, 2012